Screener
BBH vs PJP
VanEck Biotech ETF vs Invesco Pharmaceuticals ETF
Key differences
- BBH costs 0.22% less per year.
- Over the last 3 years, PJP has delivered higher annualized returns.
- PJP has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| BBH | PJP | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.57% |
| Fund size (AUM) | $365M | $334M |
| Since | 2011 | 2005 |
| Dividend yield | 0.52% | 1.01% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +26.8% | +38.9% |
| CAGR 3Y | +5.9% | +14.0% |
| CAGR 5Y | +1.2% | +7.4% |
| Sharpe 3Y | 0.21 | 0.69 |
| Volatility 1Y | 18.82% | 16.19% |
| Max drawdown | -39.86% | -33.95% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to BBH and PJP
Explore further